Next-generation cell and gene therapies are revolutionizing cancer treatment by targeting the disease at its genetic and cellular roots. These cutting-edge approaches integrate advanced gene-editing tools, synthetic biology, and precision delivery systems to reprogram immune and tumor cells for lasting therapeutic benefit. Innovations such as CAR-T and TCR-engineered cells, oncolytic viruses, and gene-modified stem cells are offering unprecedented potential to achieve durable remissions and overcome resistance to conventional therapies. The convergence of genomics, artificial intelligence, and personalized medicine is accelerating the development of safer, more effective treatment strategies tailored to individual patients.
In this session at the Cancer Research and Development Conference 2026, exciting breakthroughs that will lead the next wave of cell and gene therapies in oncology will be highlighted. The latest clinical progress, regulatory considerations, and technological advancements that are driving this fast-emerging field will be deliberated upon. Join us as we explore how innovation, precision, and transformational science are reshaping the future of cancer care with next-generation therapeutic platforms.